Thromboprophylaxis in the critically Ill Low Molecular Weight Heparin versus unfractionated Heparin

被引:1
|
作者
Petros, S. [1 ]
机构
[1] Univ Klinikum Leipzig, Interdisziplinare Internist Intens Med, Zentrum Hamostaseol, Liebigstr 20, D-04103 Leipzig, Germany
关键词
VENOUS THROMBOEMBOLISM; PROPHYLAXIS; PREVENTION; CARE; RISK;
D O I
10.1007/s00063-015-0087-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:55 / 56
页数:2
相关论文
共 50 条
  • [1] Use of unfractionated heparin (UH) versus low molecular weight heparin (LMWH) in critically ill dogs
    Thorneloe, C.
    Bedard, C.
    Boysen, S.
    Dunn, M.
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2008, 22 (03) : 775 - 776
  • [2] Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer
    Akl, Elie A.
    Kahale, Lara
    Sperati, Francesca
    Neumann, Ignacio
    Labedi, Nawman
    Terrenato, Irene
    Barba, Maddalena
    Sempos, Elena V.
    Muti, Paola
    Cook, Deborah
    Schuenemann, Holger
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (06):
  • [3] Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer
    Akl, Elie A.
    Labedi, Nawman
    Terrenato, Irene
    Barba, Maddalena
    Sperati, Francesca
    Sempos, Elena V.
    Muti, Paola
    Cook, Deborah
    Schuenemann, Holger
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (11):
  • [4] Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients
    McGarry, LJ
    Thompson, D
    Weinstein, MC
    Goldhaber, SZ
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2004, 10 (09): : 632 - 642
  • [5] Thromboprophylaxis with low molecular weight heparin (dalteparin) compared with unfractionated heparin in pregnancy.
    Kaaja, R
    Pettilä, V
    Leinonen, P
    Ikkala, E
    [J]. BLOOD, 1998, 92 (10) : 360A - 360A
  • [6] Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients
    Volteas, Panagiotis
    Drakos, Panagiotis
    Alkadaa, Leor N.
    Cleri, Nathaniel A.
    Asencio, Anthony A.
    Oganov, Anthony
    Giannopoulos, Stefanos
    Saadon, Jordan R.
    Mikell, Charles B., III
    Rubano, Jerry A.
    Labropoulos, Nicos
    Tassiopoulos, Apostolos K.
    Mofakham, Sima
    Bannazadeh, Mohsen
    [J]. JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2022, 10 (05) : 1128 - 1136
  • [7] Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer
    Van Matre, E. T.
    Reynolds, P. M.
    MacLaren, R.
    Mueller, S. W.
    Wright, G. C.
    Moss, M.
    Burnham, E. L.
    Ho, P. M.
    Vandivier, R. W.
    Kiser, T. H.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (12) : 2492 - 2500
  • [8] Dalteparin versus Unfractionated Heparin in Critically Ill Patients
    Cook, Deborah
    Meade, Maureen
    Guyatt, Gordon
    Walter, Stephen
    Heels-Ansdell, Diane
    Warkentin, Theodore E.
    Zytaruk, Nicole
    Crowther, Mark
    Geerts, William
    Cooper, D. Jamie
    Vallance, Shirley
    Qushmaq, Ismael
    Rocha, Marcelo
    Berwanger, Otavio
    Vlahakis, Nicholas E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (14): : 1305 - 1314
  • [9] Unfractionated and low molecular weight heparin
    Marcelo Lima
    Helena Nader
    [J]. BMC Proceedings, 8 (Suppl 4)
  • [10] Prophylactic Low-Molecular-Weight Heparin Versus Unfractionated Heparin at the Time of Delivery
    Pluym, Ilina D.
    Holliman, Kerry
    Bermudez, Ana
    Afshar, Yalda
    Silverman, Neil S.
    Rao, Rashmi
    [J]. OBSTETRICS AND GYNECOLOGY, 2020, 135 : 132S - 132S